Home/Filings/4/0001640455-22-000017
4//SEC Filing

MURRAY RICHARD /CA/ 4

Accession 0001640455-22-000017

CIK 0001640455other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 7:37 PM ET

Size

6.5 KB

Accession

0001640455-22-000017

Insider Transaction Report

Form 4
Period: 2022-02-01
MURRAY RICHARD /CA/
DirectorCEO and President
Transactions
  • Award

    Common Stock

    2022-02-01+87,500273,077 total
  • Award

    Stock Option (Right to Buy)

    2022-02-01+175,000175,000 total
    Exercise: $7.56Exp: 2032-02-01Common Stock (175,000 underlying)
Footnotes (1)
  • [F1]The option will vest quarterly in 16 equal installments following January 1, 2022.

Issuer

Jounce Therapeutics, Inc.

CIK 0001640455

Entity typeother

Related Parties

1
  • filerCIK 0001242935

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:37 PM ET
Size
6.5 KB